Martha Cecilia Botero Rovira, PA-C

Martha Botero Rovira practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Martha Botero Rovira's NPI, 1922581636, was assigned on September 9, 2018. Martha Botero Rovira holds Florida license PA9111516.

Martha Botero Rovira's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Martha Botero Rovira's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Martha Botero Rovira to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Martha Botero Rovira practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Martha Botero Rovira's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Martha Botero Rovira is licensed in Florida.

Dmand AI lists larynx and vocal cord disease, upper respiratory infection (URI) and yeast infection among the conditions Martha Botero Rovira treats.

CMS data shows 100 Medicare services from Martha Botero Rovira across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $5,174 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Martha Botero Rovira in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Martha Botero Rovira's median patient age at 71, with 50% women.

In 2024, Martha Botero Rovira wrote 429 Medicare Part D claims for 130 patients. 86% of them were for generic drugs. CMS names the drug for 332 of them, across 12 drugs with 11 or more claims each, at $5,047 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Martha Botero Rovira for performance year 2024, reported as part of a group. Martha Botero Rovira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Martha Botero Rovira as offering telehealth.

CMS Open Payments shows 11 general payments to Martha Botero Rovira from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Servier Pharmaceuticals LLC paid the most, $49.